MantiSpectra releases new hyperspectral sensor chip
The company says that its new product, ChipSense 2.0-16, is smaller and more accurate than the previous generation, offering expanded capabilities in biomarker measurement and industrial quality control
MantiSpectra has announced the alpha release of its spectral sensing component ChipSense 2.0-16. According to the company, this product is smaller, cheaper and more accurate than its predecessor, and enables material analysis and health insights for high-volume markets.
ChipSense 2.0-16 integrates 16 photodetectors, each with 4 multi-peak responses spanning 550-1700 nm, the key region for chemometric analysis. MantiSpectra says these rich “spectral fingerprints,” combined with AI modelling, make it a foundational element for applications where (bio)material classification and quantification are essential.
With a 4×4 mm footprint and enhanced selectivity, the company says ChipSense 2.0-16 unlocks measurement of biomarkers that are inaccessible in current wearables, new smart functions in home appliances, and quality control in industrial settings.
“ChipSense 2.0-16 is the first product manufactured by our supply chain partners, marking MantiSpectra’s transition from a technology company to a fabless, scalable, and reliable component supplier,” said Maurangelo Petruzzella, CEO of MantiSpectra. “This release enables consumer and professional solution providers to integrate real-time material analysis and health insights into disruptive products.”
